Thursday, 21 Mar 2019

You are here

Opioids No Better than NSAIDs at Chronic Pain

JAMA reports that the SPACE trial demonstrates patients with chronic back or arthritis pain respond equally to 12 months of either opioids or non-opioid (acetaminophen or NSAIDs) analgesics. (citation source:bit.ly/2tpquTM)

The study enrolled 240 patients from the Veterans Affairs primary care colinics with chronic pain in the back, knees or hips.  Patients were randomized to receive opioid vs nonopioid therapy and over 12 months were assessed for pain-related function (Brief Pain Inventory [BPI] . 

All patients followed a treat-to-target strategy aiming for improved pain and function. Opioid patients were given immediate-release morphine, that could be followed by hydrocodone/acetaminophen, or immediate release oxycodone and lastly a long-acting morphine or oxycodone or fentanyl patches.  

The nonopioid group received acetaminophen or a nonsteroidal anti-inflammatory drug. If ineffective therapy could be escalated to gabapentin, topical lidocaine, pregabalin or even tramadol.

The mean age was 58.3 years, 13% were women, and 97.5% completed the trial.

Groups did not significantly differ on pain-related function over 12 months (overall P = .58).  Pain intensity started at 5.4 for both groups but fell significantly more with nonopioids (3.5) than opioids (4.0) after 12 months (overall P = .03).

On the other hand, adverse events were significantly more common in the opioid group (1.8 vs. 0.9;  P = .03).

These results do not support the use of opioids as initial therapy in those with moderate to severe chronic back pain or hip or knee osteoarthritis pain. These results do not apply to management of cancer related pain.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

New Sleep Medicine Guidelines for Obstructive Sleep Apnea

The American Academy of Sleep Medicine (AASM) has established new guidelines for the evaluation and treatment of sleep-disordered breathing in adults, specifically guiding the use of positive airway pressure (PAP) in the treatment of obstructive sleep apnea (OSA) in adults. 

Pain Drives the Use of Medical Marijuana

A report from the University of Michigan examined state-wide medical marijuana showing most of it is used for chronic pain.

The authors include Kevin Boehnke, Ph.D., Daniel J. Clauw, M.D., Rebecca L. Haffajee, Ph.D., and Saurav Gangopadhyay, M.P.H. undertook this investigation to to assess why people are using cannabis medically. 

Compounded Pain Creams - Expensive Placebos?

The Annals of Internal Medicine reports that the growth and use of compounded pain creams is unwarranted as they were no better than placebo in a randomized controlled trial, suggesting their higher costs are unjustifiable compared to other topical commercially available agents (lidocaine, diclofenac, capsaicin, etc.). (Citation source: https://buff.ly/2BkTj58)

Opioids Double Rates of Suicides and Overdoses

An article in the New England Journal of Medicine reports that the rates of suicide and drug overdoses has doubled in the last 17 years, and that opioids are largely to blame.

Using data from the Centers for Disease Control and Prevention databases, researchers show that the sheer number of deaths from suicides and unintentional overdoses together rose from 41,364 in the year 2000 to 110,749 in 2017.

Cryotherapy Never FDA Approved

Another injury related to whole body cryotherapy (WBC) has been reported by practitioners in Philadelphia, serving as yet another warning of WBC's potential to cause serious adverse effects.